Properties of RNA polymerase II elongation complexes before and after the P-TEFb-mediated transition into productive elongation

被引:121
作者
Cheng, Bo
Price, David H. [1 ]
机构
[1] Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA
[2] Univ Iowa, Mol & Cellular Biol Program, Iowa City, IA 52242 USA
关键词
D O I
10.1074/jbc.M702936200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
The positive transcription elongation factor, P-TEFb, controls the fraction of initiated RNA polymerase II molecules that enter into the productive mode of elongation necessary to generate mRNAs. To better understand the mechanism of this transition into productive elongation we optimized a defined in vitro transcription system and compared results obtained with it to those obtained with a crude system. We found that controlling the function of TFIIF is a key aspect of RNA polymerase II elongation control. Before P-TEFb function, early elongation complexes under the control of negative factors are completely unresponsive to the robust elongation stimulatory activity of TFIIF. P-TEFb-mediated phosphorylation events, targeting the elongation complex containing DSIF and NELF, reverse the negative effect of DSIF and NELF and simultaneously facilitate the action of TFIIF. We also found that productive elongation complexes are completely resistant to negative elongation factors. Our data suggest that an additional factor(s) is involved in establishing the unique resistance activities of the elongation complexes before and after P-TEFb function. Furthermore, we provide evidence for the existence of another positive activity required for efficient function of P-TEFb. A model of the mechanism of P-TEFb-mediated elongation control is proposed in which P-TEFb induces the transition into productive elongation by changing the accessibility of elongation factors to elongation complexes. Our results have uncovered important properties of elongation complexes that allow a more complete understanding of how P-TEFb controls the elongation phases of transcription by RNA polymerase II.
引用
收藏
页码:21901 / 21912
页数:12
相关论文
共 54 条
[1]
Adamson TE, 2003, METHOD ENZYMOL, V371, P264
[2]
Transcriptional pausing caused by NELF plays a dual role in regulating immediate-early expression of the junB gene [J].
Aida, Masatoshi ;
Chen, Yexi ;
Nakajima, Koichi ;
Yamaguchi, Yuki ;
Wada, Tadashi ;
Handa, Hiroshi .
MOLECULAR AND CELLULAR BIOLOGY, 2006, 26 (16) :6094-6104
[3]
ELONGIN (SIII) - A MULTISUBUNIT REGULATOR OF ELONGATION BY RNA-POLYMERASE-II [J].
ASO, T ;
LANE, WS ;
CONAWAY, JW ;
CONAWAY, RC .
SCIENCE, 1995, 269 (5229) :1439-1443
[4]
REGULATION OF TRANSCRIPTIONAL ELONGATION BY RNA-POLYMERASE-II [J].
BENTLEY, DL .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 1995, 5 (02) :210-216
[5]
RNA polymerase II carboxy-terminal domain phosphorylation is required for cotranscriptional pre-mRNA splicing and 3′-end formation [J].
Bird, G ;
Zorio, DAR ;
Bentley, DL .
MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (20) :8963-8969
[6]
HEXIM2, a HEXIM1-related protein, regulates positive transcription elongation factor b through association with 7SK [J].
Byers, SA ;
Price, JP ;
Cooper, JJ ;
Li, QT ;
Price, DH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (16) :16360-16367
[7]
Flavopiridol inhibits P-TEFb and blocks HIV-1 replication [J].
Chao, SH ;
Fujinaga, K ;
Marion, JE ;
Taube, R ;
Sausville, EA ;
Senderowicz, AM ;
Peterlin, BM ;
Price, DH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (37) :28345-28348
[8]
Flavopiridol inactivates P-TEFb and blocks most RNA polymerase II transcription in vivo [J].
Chao, SH ;
Price, DH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (34) :31793-31799
[9]
Dynamics of human immunodeficiency virus transcription: P-TEFb phosphorylates RD and dissociates negative effectors from the transactivation response element [J].
Fujinaga, K ;
Irwin, D ;
Huang, YH ;
Taube, R ;
Kurosu, T ;
Peterlin, BM .
MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (02) :787-795
[10]
Gene-specific requirement for P-TEFb activity and RNA polymerase II phosphorylation within the p53 transcriptional program [J].
Gomes, NP ;
Bjerke, G ;
Llorente, B ;
Szostek, SA ;
Emerson, BM ;
Espinosa, JM .
GENES & DEVELOPMENT, 2006, 20 (05) :601-612